Ken Declerck
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Phytochemicals and Medicinal Plants
Papers in
-
- Phytochemicals and Medicinal Plants 2
- Mangiferin and Mango Extracts 2
-
- Epigenetics and DNA Methylation 7
- RNA modifications and cancer 3
- Co-authors
- Wim Vanden Berghe (25 shared papers)Katarzyna Szarc vel Szic (8 shared papers)Melita Vidaković (1 shared paper)Guy Van Camp (6 shared papers)Karen Heyninck (4 shared papers)Patrick De Boever (2 shared papers)Sabine A. S. Langie (2 shared papers)Gudrun Koppen (2 shared papers)
In The Last Decade
Ken Declerck
29 papers receiving 1.5k citations
Ken Declerck's Hit Papers
Peers
Comparison fields: 5 of 108
- Cancer Research 348
- Complementary and alternative medicine 136
- Aging 28
- Pulmonary and Respiratory Medicine 427
- Molecular Biology 723
Countries citing papers authored by Ken Declerck
This map shows the geographic impact of Ken Declerck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Declerck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Declerck more than expected).
Fields of papers citing papers by Ken Declerck
This network shows the impact of papers produced by Ken Declerck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Declerck. The network helps show where Ken Declerck may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Declerck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma Hit paper breakdown → | 2018 | 548 |
| 2 | 2015 | 159 | |
| 3 | 2014 | 83 | |
| 4 | 2018 | 81 | |
| 5 | 2016 | 68 | |
| 6 | 2017 | 57 | |
| 7 | 2014 | 49 | |
| 8 | 2016 | 45 | |
| 9 | 2017 | 42 | |
| 10 | 2019 | 36 | |
| 11 | 2020 | 33 | |
| 12 | 2017 | 32 | |
| 13 | 2018 | 32 | |
| 14 | 2015 | 30 | |
| 15 | 2019 | 26 | |
| 16 | 2015 | 24 | |
| 17 | 2019 | 24 | |
| 18 | 2021 | 21 | |
| 19 | 2022 | 17 | |
| 20 | 2017 | 13 |
About Ken Declerck
Ken Declerck is a scholar working on Complementary and alternative medicine, Molecular Biology, Immunology, Genetics and Neurology, having authored 30 papers that have together received 1.5k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (7 papers), RNA modifications and cancer (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Autophagy in Disease and Therapy (2 papers), Nutrition, Genetics, and Disease (2 papers), Phytochemicals and Medicinal Plants (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers) and Mangiferin and Mango Extracts (2 papers). The work is most often cited by research in Cancer Research (348 citations), Complementary and alternative medicine (136 citations), Aging (28 citations), Pulmonary and Respiratory Medicine (427 citations) and Molecular Biology (723 citations). Ken Declerck has collaborated with scholars based in Belgium, France and Germany. Frequent co-authors include Wim Vanden Berghe, Katarzyna Szarc vel Szic, Melita Vidaković, Guy Van Camp, Karen Heyninck, Patrick De Boever, Sabine A. S. Langie, Gudrun Koppen, Dragan Milenković and Clarissa Gerhäuser. Their work appears in journals such as PLoS ONE, Clinical Epigenetics, Scientific Reports, Marine Drugs and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.